✦ LIBER ✦

959 PUBLICATION Evaluation of gefinitib in combination with tamoxifen in ovarian cancer patients refractory to platinum-taxane chemotherapy — results of a phase II study (ovar 2.6) of the AGO

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib in combination with tamoxifen

✍ Uwe Wagner; Andreas du Bois; Jacobus Pfisterer; Jens Huober; Sybille Loibl; Hans 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A Phase II, randomized, double-blind stu

✍ Cognetti, F.; Bagnato, A.; Colombo, N.; Savarese, A.; Scambia, G.; Sehouli, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Phase II Study of Intravenous DX-8951f i

✍ C. F. VERSCHRAEGEN; C. LEVENBACK; M. VINCENT; J. WOLF; M. BEVERS; E. LOYER; A. P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Addition of vandetanib to pegylated lipo

✍ Harter, Philipp; Sehouli, Jalid; Kimmig, Rainer; Rau, JÃ¶rn; Hilpert, Felix; Kur 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 162 KB

A randomized phase II study evaluating t

✍ Kaye, S. B.; Poole, C. J.; Danska-Bidzinska, A.; Gianni, L.; Del Conte, G.; Gorb 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 251 KB

Docetaxel and carboplatin as first-line

✍ J Pfisterer; A du Bois; U Wagner; J Quaas; J.U Blohmer; D Wallwiener; F Hilpert 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 123 KB